Ajooni Biotech Ltd
NSE:AJOONI
Ajooni Biotech Ltd
NSE:AJOONI
Price:
4.26
INR
Market Closed
Market Cap:
₹733.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Ajooni Biotech Ltd
NSE:AJOONI
|
IN |
Income Statement
Earnings Waterfall
Ajooni Biotech Ltd
Ajooni Biotech Ltd
Income Statement
Ajooni Biotech Ltd
Ajooni Biotech Ltd
Currency: INR
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||
| Revenue |
740
N/A
|
863
+17%
|
624
-28%
|
537
-14%
|
745
+39%
|
832
+12%
|
924
+11%
|
1 018
+10%
|
801
-21%
|
848
+6%
|
910
+7%
|
1 050
+15%
|
1 147
+9%
|
1 203
+5%
|
1 263
+5%
|
1 510
+20%
|
|
| Gross Profit | |||||||||||||||||
| Cost of Revenue |
(640)
|
(743)
|
(537)
|
(450)
|
(657)
|
(743)
|
(836)
|
(933)
|
(703)
|
(740)
|
(790)
|
(896)
|
(970)
|
(999)
|
(1 023)
|
(1 215)
|
|
| Gross Profit |
100
N/A
|
120
+20%
|
87
-27%
|
88
+0%
|
87
0%
|
89
+2%
|
87
-2%
|
84
-3%
|
98
+16%
|
108
+10%
|
121
+12%
|
155
+28%
|
177
+14%
|
204
+16%
|
240
+18%
|
296
+23%
|
|
| Operating Income | |||||||||||||||||
| Operating Expenses |
(80)
|
(96)
|
(71)
|
(76)
|
(70)
|
(72)
|
(69)
|
(77)
|
(84)
|
(91)
|
(102)
|
(120)
|
(151)
|
(180)
|
(209)
|
(250)
|
|
| Selling, General & Administrative |
(55)
|
(60)
|
(57)
|
(57)
|
(50)
|
(50)
|
(51)
|
(52)
|
(64)
|
(64)
|
(66)
|
(69)
|
(123)
|
(127)
|
(131)
|
(134)
|
|
| Depreciation & Amortization |
(10)
|
(14)
|
(11)
|
(11)
|
(10)
|
(10)
|
(9)
|
(9)
|
(9)
|
(9)
|
(9)
|
(9)
|
(11)
|
(11)
|
(11)
|
(17)
|
|
| Other Operating Expenses |
(16)
|
(22)
|
(3)
|
(8)
|
(10)
|
(12)
|
(9)
|
(17)
|
(12)
|
(19)
|
(29)
|
(44)
|
(17)
|
(43)
|
(67)
|
(99)
|
|
| Operating Income |
20
N/A
|
25
+25%
|
16
-35%
|
12
-26%
|
18
+47%
|
17
-3%
|
18
+5%
|
7
-60%
|
14
+91%
|
16
+21%
|
18
+7%
|
33
+89%
|
26
-22%
|
23
-10%
|
30
+31%
|
46
+50%
|
|
| Pre-Tax Income | |||||||||||||||||
| Interest Income Expense |
0
|
(6)
|
(4)
|
(5)
|
2
|
(5)
|
(6)
|
(6)
|
5
|
(6)
|
(4)
|
(4)
|
9
|
(3)
|
(4)
|
(5)
|
|
| Gain/Loss on Disposition of Assets |
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
(5)
|
0
|
0
|
0
|
(4)
|
4
|
6
|
22
|
11
|
22
|
22
|
10
|
8
|
27
|
25
|
25
|
|
| Pre-Tax Income |
15
N/A
|
19
+29%
|
12
-35%
|
8
-37%
|
16
+103%
|
16
-2%
|
19
+21%
|
23
+25%
|
30
+28%
|
32
+8%
|
35
+8%
|
39
+12%
|
43
+10%
|
47
+9%
|
52
+9%
|
65
+26%
|
|
| Net Income | |||||||||||||||||
| Tax Provision |
(4)
|
(5)
|
(3)
|
(1)
|
(5)
|
(4)
|
(4)
|
(6)
|
(8)
|
(8)
|
(9)
|
(10)
|
(10)
|
(11)
|
(12)
|
(16)
|
|
| Income from Continuing Operations |
10
|
14
|
9
|
6
|
11
|
12
|
14
|
18
|
22
|
24
|
26
|
29
|
34
|
37
|
40
|
49
|
|
| Net Income (Common) |
10
N/A
|
14
+31%
|
9
-32%
|
6
-32%
|
11
+78%
|
12
+7%
|
15
+21%
|
18
+23%
|
22
+21%
|
24
+12%
|
26
+9%
|
29
+11%
|
34
+15%
|
37
+9%
|
40
+9%
|
49
+23%
|
|
| EPS (Diluted) |
0.16
N/A
|
0.26
+63%
|
0.17
-35%
|
0.06
-65%
|
0.11
+83%
|
0.13
+18%
|
0.14
+8%
|
0.17
+21%
|
0.22
+29%
|
0.14
-36%
|
0.15
+7%
|
0.16
+7%
|
0.2
+25%
|
0.22
+10%
|
0.34
+55%
|
0.32
-6%
|
|
Switch to:
Switch to:
See Also
Discover More
